The “plausible mechanism pathway” will allow personalised drugs to reach the market sooner for patients with genetic diseases ...
Through substantial leadership turnover and workforce cuts, the FDA has continued to support the advanced therapy sector, ...
Poherdy is the first FDA-approved interchangeable biosimilar to Perjeta for HER2-positive breast cancer, potentially expanding access and reducing costs. Approved for use in combination with ...
OBESITY IS A SERIOUS PROBLEM IN OUR STATE. AND DRUGS TO TREAT IT ARE EXPENSIVE. NOW SOME GROUPS ARE ASKING THE GOVERNOR TO ...
The smart thermometer performs a check-up on your body temperature, cardiac, and pulmonary health in less than a minute.
The FDA has removed a long-standing black box warning from menopause hormone therapies. This decision reverses decades of ...
As deadly drug overdoses climbed across Canada, decision-makers faced political backlash for funding programs that gave drug ...
House Bill 324 would ban mail-order sales of certain medications and require in-person doctor visits. Abortion rights ...
The new EU regulation introduces Joint Clinical Assessments that will run in parallel with EMA approvals, delivering comparative effectiveness data within one month of market authorisation.
15don MSN
'We don’t have time': Parents of 4-year-old with rare disorder urge FDA to reconsider drug denial
The FDA denied approving DCA to treat a rare disorder called PDCD. The Higbees are urging the agency to reconsider.
Article updated to correct “Jim Krieg” to “James Kreig” MALVERN, PENNSYLVANIA / ACCESS Newswire / November 12, 2025 / Pace ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback